Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Drug-induced akathisia].

P N van Harten1

  • 1hartenp@knmg.nl

Nederlands Tijdschrift Voor Geneeskunde
|February 6, 2002
PubMed
Summary

Akathisia, a distressing side effect of dopamine-blocking drugs, affects 20-30% of patients on classical antipsychotics. Treatment involves dose reduction, switching medications, or adding specific agents.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness and implementation of a multidisciplinary lifestyle focused approach in the treatment of inpatients with mental illness (MULTI +): a stepped wedge study protocol.

BMC psychiatry·2022
Same author

[CYP2D6 and CYP2C19 genotyping: effectivity in psychiatric practice]

Tijdschrift voor psychiatrie·2021
Same author

[Thinking inside the box: improving the lifestyle of inpatients with severe mental illness].

Tijdschrift voor psychiatrie·2020
Same author

Efficacy of amantadine on behavioural problems due to acquired brain injury: A systematic review.

Brain injury·2019
Same author

Tijdschrift voor psychiatrie·2018
Same author

Commentary on "Motor system dysfunction in the schizophrenia diathesis: Neural systems to neurotransmitters".

European psychiatry : the journal of the Association of European Psychiatrists·2018

Area of Science:

  • Psychiatry
  • Pharmacology

Background:

  • Akathisia is a common and distressing extrapyramidal side effect of dopamine-blocking agents.
  • It is often mistaken for psychotic agitation or restless legs syndrome, complicating diagnosis and management.
  • Non-compliance with essential medications is a frequent consequence of akathisia.

Purpose of the Study:

  • To review the prevalence, risk factors, and management strategies for akathisia.
  • To differentiate akathisia from other conditions with similar presentations.
  • To inform clinical practice regarding the identification and treatment of this side effect.

Main Methods:

  • Literature review of studies on antipsychotic-induced movement disorders.
  • Analysis of prevalence data for classical and atypical antipsychotics.
  • Summary of current treatment guidelines and pharmacological options.

Main Results:

  • Prevalence of akathisia is 20-30% with classical antipsychotics, lower with atypical agents like clozapine, olanzapine, and quetiapine.
  • Key risk factors include high antipsychotic dosage, prior history of akathisia, and diabetes mellitus.
  • Treatment options include dose reduction, antipsychotic switching, or adjunctive therapies such as beta-blockers, anticholinergics, or mianserin.

Conclusions:

  • Akathisia is a significant adverse drug reaction requiring careful distinction from other conditions.
  • Management strategies focus on dose adjustment, medication changes, and symptomatic treatment.
  • Understanding risk factors and treatment options is crucial for patient compliance and therapeutic success.

Related Experiment Videos